Beryl Therapeutics

Private

Longmont, ColoradoHealthcare & Life Sciences

Last Round

Grant

May 18, 2023

Total Funding Raised

$250,000

Company Overview

Beryl Therapeutics is a biotechnology company that develops patented small molecule therapies to increase bone mass and treat bone diseases such as osteoporosis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverysmall-molecule therapeuticsbone healthlipidomicsosteoporosis treatmentbone mineral densityBMDpre-clinical developmentbiopharmatherapeutic pipelinedrug developmentlipid signalingbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beryl Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Beryl Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Beryl Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	May 18, 2023

View all Funding Rounds

Beryl Therapeutics Investors

Notable investors and investment history

Beryl Therapeutics investors
Investor	Rounds
Foundation for Prader-Willi Research	Seed
Advanced Industries Accelerator Program	Grant

View all Investors

Beryl Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Beryl Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beryl Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLongmont, Colorado

Year Founded2018

Last FundingMay 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.